sulbactam has been researched along with Kidney Diseases in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (66.67) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Marshall, S; Muto, C; Shoji, S; Soto, E; Tomono, Y | 1 |
| Wise, R; Wright, N | 1 |
| de la Pena, A; Derendorf, H | 1 |
| Bruckner, G; Hampel, B; Koeppe, P; Lode, H | 1 |
| Blum, RA; Harrison, NJ; Kohli, RK; Schentag, JJ | 1 |
| Marble, DA; Reitberg, DP; Schentag, JJ; Schultz, RW; Whall, TJ | 1 |
2 review(s) available for sulbactam and Kidney Diseases
| Article | Year |
|---|---|
Pharmacokinetic properties of beta-lactamase inhibitors.
Topics: Absorption; Aging; Anti-Bacterial Agents; beta-Lactamase Inhibitors; Biological Availability; Clavulanic Acid; Drug Synergism; Enzyme Inhibitors; Half-Life; Humans; Kidney Diseases; Penicillanic Acid; Sulbactam; Tazobactam | 1999 |
The pharmacokinetics of sultamicillin.
Topics: Amoxicillin; Ampicillin; Clavulanic Acid; Clavulanic Acids; Drug Therapy, Combination; Humans; Kidney Diseases; Prodrugs; Sulbactam | 1989 |
1 trial(s) available for sulbactam and Kidney Diseases
| Article | Year |
|---|---|
Population pharmacokinetics of ampicillin and sulbactam in patients with community-acquired pneumonia: evaluation of the impact of renal impairment.
Topics: Adult; Aged; Aged, 80 and over; Ampicillin; Anti-Bacterial Agents; Community-Acquired Infections; Computer Simulation; Drug Administration Schedule; Drug Combinations; Drug Dosage Calculations; Female; Humans; Infusions, Intravenous; Japan; Kidney; Kidney Diseases; Male; Metabolic Clearance Rate; Microbial Sensitivity Tests; Middle Aged; Models, Biological; Pneumonia, Bacterial; Sulbactam | 2014 |
3 other study(ies) available for sulbactam and Kidney Diseases
| Article | Year |
|---|---|
The elimination of sulbactam alone and combined with ampicillin in patients with renal dysfunction.
Topics: Ampicillin; Drug Combinations; Half-Life; Humans; Kidney Diseases; Penicillanic Acid; Sulbactam | 1983 |
Pharmacokinetics of ampicillin (2.0 grams) and sulbactam (1.0 gram) coadministered to subjects with normal and abnormal renal function and with end-stage renal disease on hemodialysis.
Topics: Adult; Ampicillin; Chromatography, High Pressure Liquid; Female; Half-Life; Humans; Injections, Intravenous; Kidney Diseases; Kidney Failure, Chronic; Male; Renal Dialysis; Sulbactam | 1989 |
Pharmacokinetics of cefoperazone (2.0 g) and sulbactam (1.0 g) coadministered to subjects with normal renal function, patients with decreased renal function, and patients with end-stage renal disease on hemodialysis.
Topics: Adult; Aged; Cefoperazone; Female; Humans; Infusions, Intravenous; Kidney Diseases; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis; Sulbactam | 1988 |